CN1552386A - Medicine for treating human lithic disease - Google Patents
Medicine for treating human lithic disease Download PDFInfo
- Publication number
- CN1552386A CN1552386A CNA031267971A CN03126797A CN1552386A CN 1552386 A CN1552386 A CN 1552386A CN A031267971 A CNA031267971 A CN A031267971A CN 03126797 A CN03126797 A CN 03126797A CN 1552386 A CN1552386 A CN 1552386A
- Authority
- CN
- China
- Prior art keywords
- radix
- rhizoma
- medicine
- disease
- herba
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
A Chinese medicine for treating calculi is prepared from 19 Chinese-medicinal materials including talc, lysimachia, giant knotweed rhizome, rhubarb, etc. Its advantages are high cure rate (more than 95%) and high safety.
Description
Technical field
This utility model relates to the Chinese patent medicine of the treatment calculosis disease that a kind of traditional traditional Chinese medical science uses, be meant especially a kind of to each position, various calculosis all have curative effect, lithodialysis, fossil, painless urinary calculus removing Chinese patent medicine.
Background technology
Calculus is a kind of multiple disease, mainly by environmental pollution, psychentonia, eating and drinking without temperance, drinking-water less at ordinary times, physical function is impaired etc., and the unusual condensing crystallizing oxidation of body fluid is formed.Theory of Chinese medical science think calculus all by the foul stasis of blood stagnate, FU QI being obstructed, damp and hot continuing do and be trouble, its formation be one by liquid state to solid-state process.Clinically, calculus is commonly encountered diseases, frequently-occurring disease, and present Therapeutic Method and prescription do not have big breakthrough.Three kinds of methods of now many employings: the first takes operation method to take out calculus, and this therapy has certain risk, and the wound that patient suffers is big, and medical expense is comparatively expensive; It two is to take the ultrasound wave lithotripsy in treatment, and this method patient suffers wound little, but not good enough for calculus patient effect really up to the mark, even can not cure by ultrasound wave rubble method, and the medical expense height; It three is to adopt Drug therapy, wherein adopt Western medicine still not have specific medicament, general just reducing swelling and alleviating pain is difficult to stone is discharged, for Western medicine, many Chinese medicines have then been obtained good curative effect, as widely used lithagogue infusion, XIAOYAN LIDAN PIAN, AIHUO DANTONG etc. clinically, but said medicine is only effective in cure to less calculus, and calculus is surpassed one centimetre of special calculus unsatisfactory curative effect of person or position, even can not get rid of, also exist medicine time long, side effect big, calculus process misery etc.Preceding two kinds are physiotherapy, all have certain danger and nocuity, and easy infection, easily residual, easy recurrence, real method for only curing the symptoms, not the disease.
Summary of the invention
The purpose of this invention is to provide and a kind ofly can effectively dissolve calculus and with its effective discharge in the person, and to the Chinese patent medicine of calculus position, kind wide adaptability.
Designed a kind of medicine for the treatment of the calculosis disease according to above-mentioned purpose, the raw material components of this medicine comprises Asteriscus Pseudosciaenae, Radix Cudraniae, Talcum, Natrii Sulfas, Rhizoma Polygoni Cuspidati, Herba Lysimachiae, Radix Et Rhizoma Rhei, Herba Artemisiae Scopariae, Rhizoma Coptidis, Cortex Phellodendri, Spora Lygodii, Radix Curcumae, Rhizoma Corydalis, Fructus Aurantii, Semen Arecae, Endothelium Corneum Gigeriae Galli, Radix Bupleuri, the Radix Aucklandiae, Rhizoma Cyperi.
The percentage by weight of this each raw material of medicine is:
Asteriscus Pseudosciaenae 8～15% Radix Cudraniaes 10～15% Talcums 2～5%
Natrii Sulfas 2～5% Rhizoma Polygoni Cuspidati 3～8% Herba Lysimachiaes 7～15%
Radix Et Rhizoma Rhei 2～5% Herba Artemisiae Scopariaes 2～5% Spora Lygodii 7～1 5%
Radix Curcumae 5～10% Rhizoma Corydalis 3～7% Fructus Aurantiis 2～5%
Semen Arecae 5～10% Endothelium Corneum Gigeriae Galli 6～12% Radix Bupleuri 3.5～8%
The Radix Aucklandiae 1～3% Rhizoma Cyperi 1～5%
Add man-hour, can make liquor, after sterilize, pack decocting after the medicament mixed in the said components; Or,, be mixed into powder after the pulverizing or make pill by the filling machine dress more respectively through processed with salt or vinegar system with the clean back of the classification of drug in described component sterilization treatment.
The present invention by anti-inflammatory analgetic, the chest stuffiness relieving regulate the flow of vital energy, dispersing the stagnated live-QI to relieve the stagnation of QI, blood circulation promoting and blood stasis dispelling, softening the hard mass removing mass, wash six internal organs, by the cause of disease, the medicine efficacy of a drug can penetrate into calculus inside gradually after the patient took medicine, make the dissolving of calculus expansion pineization, and by the effect of function of gallbladder promoting diuretic, depletion of blood is painless, easily the calculus with different sick positions excretes.Whole process patient's dosage is little, according to only 3～20 doses of the weight dosages of disease, and safety economy, cure rate is more than 95%.
Specific embodiments
The present invention can adjust the dosage form of taking medicine, dosage according to patient's concrete disease and physical condition, and the molding medicament can be serial Chinese patent medicines such as powder, electuary, pill, tablet, capsule or even water preparation.
Embodiment 1, take by weighing herbal raw material (kilogram) by following weight proportion:
Asteriscus Pseudosciaenae 15 Radix Cudraniaes 10 Talcums 5 Natrii Sulfas 2 Rhizoma Polygoni Cuspidati 5
Herba Lysimachiae 10 Radix Et Rhizoma Rhei 3 Herba Artemisiae Scopariaes 5 Spora Lygodii 10
Radix Curcumae 5 Rhizoma Corydalis 3 Fructus Aurantiis 2 Semen Arecaes 5 Endothelium Corneum Gigeriae Galli 8
Radix Bupleuri 4 Radix Aucklandiae 3 Rhizoma Cyperis 5
Above-mentioned raw materials difference drying, pulverizing back are mixed, decoct and make liquor, after sterilize, pack, standby; Or,, be mixed into powder after the pulverizing or make pill by the filling machine dress more respectively through processed with salt or vinegar system with the clean back of the classification of drug in described component sterilization treatment.
Embodiment 2, take by weighing herbal raw material (kilogram) by following weight proportion:
Fish brain 8 is worn out 7 Talcums, 2 Natrii Sulfas, 4 Rhizoma Polygoni Cuspidati 6
Herba Lysimachiae 15 Radix Et Rhizoma Rhei 2 Herba Artemisiae Scopariaes 3 Spora Lygodii 10
Radix Curcumae 8 Rhizoma Corydalis 3 Fructus Aurantiis 2 Semen Arecaes 7 Endothelium Corneum Gigeriae Galli 6
Radix Bupleuri 5 Radix Aucklandiae 5 Rhizoma Cyperis 7
Processing method is the same.
The present invention controls by comprehensively distinguishing, has taked depressed liver-energy dispersing and function of gallbladder promoting, kidney tonifying diuresis, heat-clearing and toxic substances removing, lithodialysis softening the hard mass removing mass method, and it is remarkable to be used for clinical efficacy, and the efficacy of a drug can penetrate into calculus inside gradually after the medication, makes calculus expansion pineization, dissolving and discharge.Clinical observation hundred routine patients take the curative effect situation and add up as follows:
| Follow up a case by regular visits to | Number | Treated 3～15 days | Effective percentage % |
| Take a turn for the better | ???6 | ??????6 | |
| Produce effects | ???8 | ??????8 | |
| Cure | ???84 | ??????84 | |
| Invalid | ???2 | ||
| Add up to | ??100 | ??????98 |
Annotate: cause of invalidity 1, gallbladder necrosis, organic damage has lost the healing condition;
2, sb.'s sickness becomes critical, and serious the obstruction changes the treatment that operates on.
Claims (4)
1, a kind of medicine for the treatment of the calculosis disease is characterized in that the raw material components of this medicine comprises
Asteriscus Pseudosciaenae, Radix Cudraniae, Talcum, Natrii Sulfas, Rhizoma Polygoni Cuspidati, Herba Lysimachiae, Radix Et Rhizoma Rhei, Herba Artemisiae Scopariae, Rhizoma Coptidis, Cortex Phellodendri, Spora Lygodii, Radix Curcumae, Rhizoma Corydalis, Fructus Aurantii, Semen Arecae, Endothelium Corneum Gigeriae Galli, Radix Bupleuri, the Radix Aucklandiae, Rhizoma Cyperi.
2, medicine according to claim 1 is characterized in that the percentage by weight of this each raw material of medicine is
Asteriscus Pseudosciaenae 8～15% Radix Cudraniaes 10～15% Talcums 2～5%
Natrii Sulfas 2～5% Rhizoma Polygoni Cuspidati 5～8% Herba Lysimachiaes 7～15%
Radix Et Rhizoma Rhei 3～7% Herba Artemisiae Scopariaes 2～5% Spora Lygodii 7～15%
Radix Curcumae 5～10% Rhizoma Corydalis 3～7% Fructus Aurantiis 2～5%
Semen Arecae 5～10% Endothelium Corneum Gigeriae Galli 6～12% Radix Bupleuri 3.5～8%
The Radix Aucklandiae 3～6% Rhizoma Cyperis 5～8%
3, the preparation method of medicine according to claim 2 is characterized in that making liquor with decocting after the medicament mixed in the described component, after sterilize, pack.
4, the preparation method of medicine according to claim 2 is characterized in that the classification of drug in the described component is cleaned the back sterilization treatment, more respectively through processed with salt or vinegar system, is mixed into powder after the pulverizing or makes pill by the filling machine dress.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB031267971A CN1269520C (en) | 2003-06-05 | 2003-06-05 | Medicine for treating human lithic disease |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB031267971A CN1269520C (en) | 2003-06-05 | 2003-06-05 | Medicine for treating human lithic disease |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1552386A true CN1552386A (en) | 2004-12-08 |
| CN1269520C CN1269520C (en) | 2006-08-16 |
Family
ID=34322007
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNB031267971A Expired - Fee Related CN1269520C (en) | 2003-06-05 | 2003-06-05 | Medicine for treating human lithic disease |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1269520C (en) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101199818B (en) * | 2007-06-28 | 2010-06-02 | 周平 | Medicament compound for treating calculus |
| CN101496893B (en) * | 2009-03-06 | 2012-06-06 | 陈秀俊 | Chinese medicinal composition for treating gall stone symptom and preparation method thereof |
| CN102600425A (en) * | 2012-03-09 | 2012-07-25 | 龙步明 | Chinese herba preparation with function of breaking stones and preparation method of Chinese herba preparation |
-
2003
- 2003-06-05 CN CNB031267971A patent/CN1269520C/en not_active Expired - Fee Related
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101199818B (en) * | 2007-06-28 | 2010-06-02 | 周平 | Medicament compound for treating calculus |
| CN101496893B (en) * | 2009-03-06 | 2012-06-06 | 陈秀俊 | Chinese medicinal composition for treating gall stone symptom and preparation method thereof |
| CN102600425A (en) * | 2012-03-09 | 2012-07-25 | 龙步明 | Chinese herba preparation with function of breaking stones and preparation method of Chinese herba preparation |
| CN102600425B (en) * | 2012-03-09 | 2014-03-26 | 龙步明 | Chinese herba preparation with function of breaking stones and preparation method of Chinese herba preparation |
Also Published As
| Publication number | Publication date |
|---|---|
| CN1269520C (en) | 2006-08-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101732621A (en) | Chinese medicament for treating kidney stones | |
| CN101279083B (en) | Chinese medicine preparation for curing acute or chronic cholecystitis and method of preparing the same | |
| CN102379996B (en) | External Chinese medicament for treating scabies | |
| CN1861155A (en) | Method for preparing traditional Chinese medicine for treating rheumatism and rheumatoid disease, and said medicine thereby | |
| CN1814245A (en) | Chinese medicine remedy for treating cervical vertebra disease | |
| CN101327305A (en) | Chinese medicine for treating appendicitis and preparation method thereof | |
| CN1060391C (en) | Traditional Chinese medicine for treating gynecological tumour | |
| CN103211886A (en) | Medicament for treating rheumatic arthritis | |
| CN1269520C (en) | Medicine for treating human lithic disease | |
| CN102205009B (en) | Traditional Chinese medicine for treating urinary tract stones | |
| CN100579544C (en) | Chinese medicament preparation for treating cholecystitis and gall-stone as well as preparation method thereof | |
| CN1298384C (en) | Medicine for curing lithangiuria | |
| CN101181344B (en) | Chinese medicine medicament for curing renal calculs | |
| CN1186044C (en) | Chinese medicine 'lidandishi' for treating hepatobiliary calculus and cholecystitis | |
| CN101647880A (en) | Medicament for treating appendicitis and preparation method thereof | |
| CN102552604A (en) | Medicament for treating prostatitis and prostatic hyperplasia | |
| CN1160102C (en) | Chinese medicine for curing female chronic inflammation | |
| CN1103796A (en) | Dressing medicine for treating hyperosteogeny and the prepn. method | |
| CN103611078A (en) | Oral traditional Chinese medicine liquid for treating chronic pelvic inflammation and preparation method thereof | |
| CN108295154A (en) | A kind of drug and preparation process for treating kidney and lithangiuria | |
| CN101810709A (en) | Medicament for treating rheumatism | |
| CN1589859A (en) | Chinese medicinal composition for treating rheumatism rheumatoid arthritis and osteosis | |
| CN1840146A (en) | Medicament for treating vitiligo | |
| CN1943669A (en) | The Chinese traditional medicinal preparation for treatment of calculus | |
| CN1168472C (en) | Chinese medicine prepn for treating lupus erythematosus |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C17 | Cessation of patent right | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20060816 Termination date: 20110605 |